Patent ID: 7598028
Filing Date: 2009-10-06
Classification: C12Q,G01N

Abstract:
1. A method for characterizing prostate tissue in a subject, comprising: a) providing a sample from a subject suspected of having a prostatic disease, wherein said subject has a PSA level at or less than 10 ng/ml, wherein said sample is selected from the group consisting of prostate tissue, serum, plasma, mucus, blood, and urine; b) detecting and comparing the amount of expression of CXCL5 and CXCL12 in said prostate tissue sample; and c) characterizing said prostate tissue sample as indicative of prostate cancer or benign prostatic hyperplasia based upon said comparing, wherein a higher amount of detected CXCL12 expression than CXCL5 expression is indicative of prostate cancer, wherein a higher amount of detected CXCL12 expression than CXCL5 expression is indicative of prostate cancer.